Azithromycin 250 mg

DRUG5 trials

Sponsors

University Hospital, Ghent, University Medical Center Groningen, Centre Hospitalier Universitaire, Amiens, Centre Hôpital Universitaire Farhat Hached, Sidra Aziz

Conditions

AsthmaCOVID-19Chronic Obstructive Pulmonary Disease With ExacerbationLung InfectionMAC Lung DiseaseSARS-CoV-2 PneumoniaTuberculosis, Pulmonary

Phase 2

Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis

CompletedNCT03160638

University Medical Center GroningenTuberculosis, Pulmonary

Start: 2018-02-01End: 2022-05-22Updated: 2024-02-26

Phase 3

CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections

RecruitingNCT03236987

Centre Hospitalier Universitaire, AmiensLung Infection, MAC Lung Disease

Start: 2018-02-05End: 2029-02-05Target: 424Updated: 2025-11-19

Hydroxychloroquine, Azithromycin in the Treatment of Covid-19

Centre Hôpital Universitaire Farhat HachedCOVID-19, SARS-CoV-2 Pneumonia

Start: 2020-07-31End: 2021-03-31Target: 200Updated: 2020-06-19

Phase 4

AZISAST Study: AZIthromycin in Severe ASThma Study

CompletedNCT00760838

University Hospital, GhentAsthma

Start: 2009-03-31End: 2011-09-30Updated: 2014-06-26

Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype

Not yet recruitingNCT07795086

Sidra AzizChronic Obstructive Pulmonary Disease With Exacerbation

Start: 2027-02-01End: 2027-02-01Target: 70Updated: 2026-08-31

Related Papers

Azithromycin as Host-Directed Therapy for Pulmonary Tuberculosis: A Randomized Pilot Trial

The Journal of Infectious Diseases2025-02-113 citations

Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.

2013-01-03319 citations